Pharmacokinetics and pharmacodynamics

Abstract In this chapter, we introduce the reader to the fundamental concepts that outline pharmacokinetics (PK) and pharmacodynamics (PD). Basic terms are defined and presented along with the related mathematical equations that permit us to explore the relationships between dose, exposure, and response. Selected clinical examples are provided to assist the reader in solidifying their understanding of these concepts. It is the intent that this overview will lessen the perception that PK and PD represent a somewhat esoteric discipline.

• Publication year

  2020

• Venue

  Toxicology Cases for the Clinical and Forensic Laboratory

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Computer Science

• Identifiers
  DOI 10.1016/b978-0-12-815846-3.00002-8
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide in Healthy Subjects

  2017cited by this paper
• Paracelsus Revisited: The Dose Concept in a Complex World.

  2016cited by this paper
• Association of SCN1A gene polymorphism with antiepileptic drug responsiveness in the population of Thrace, Greece

  2016cited by this paper
• Understanding the hysteresis loop conundrum in pharmacokinetic/pharmacodynamic relationships.

  2014cited by this paper
• Drug-Induced Long QT Syndrome in Women

  2013cited by this paper
• Molecular Mechanisms of Insulin Resistance in Humans and Their Potential Links With Mitochondrial Dysfunction

  2006cited by this paper
• Pharmacokinetics and pharmacodynamics of methyl parathion.

  2002cited by this paper
• Single dose pharmacokinetics of pleconaril in neonates. Pediatric Pharmacology Research Unit Network.

  2000cited by this paper
• Developmental changes in pharmacokinetics and pharmacodynamics of warfarin enantiomers in Japanese children

  2000cited by this paper
• Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance

  1987cited by this paper
• Use of chloramphenicol palmitate in neonates.

  1984cited by this paper
• Aminoglycoside-selected subpopulations of Pseudomonas aeruginosa: characterization and virulence in normal and leukopenic mice.

  1982cited by this paper
• Physiologic cholestasis: Elevation of the primary serum bile acid concentrations in normal infants

  1981cited by this paper
• Pharmacokinetics of gentamicin in children and adults.

  1975cited by this paper
• Experience in Monitoring Gentamicin Therapy during Treatment of Serious Gram-Negative Sepsis

  1974cited by this paper
• Correlative study of hydrochloric acid, pepsin, and intrinsic factor secretion in newborns and infants

  1969cited by this paper
• BILE ACIDS IN INFANTS AND CHILDREN.

  1964cited by this paper
• Comparison of serum levels following the administration of oral and parenteral preparations of penicillin to infants and children of various age groups.

  1953cited by this paper
• Dose-response: an International Journal Dissection of the Hormetic Curve: Analysis of Components and Mechanisms Dissection of the Hormetic Curve: Analysis of Components and Mechanisms

  year unknowncited by this paper

• No citing papers are available for this paper.